This Week in Addiction Medicine from ASAM
Episodes
Lead: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
17 Mar 2026
Contributed by Lukas
Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study The BMJ This study ...
Lead: Does the total consumption model apply to cannabis use?
12 Mar 2026
Contributed by Lukas
Does the total consumption model apply to cannabis use? Addiction This repeated cross-sectional study based on annual surveys tested whether the total...
Lead: Spirituality and Harmful or Hazardous Alcohol and Other Drug Use
03 Mar 2026
Contributed by Lukas
Spirituality and Harmful or Hazardous Alcohol and Other Drug Use JAMA Psychiatry This meta-analysis of 55 rigorous studies on spirituality and harmf...
Lead: Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
24 Feb 2026
Contributed by Lukas
Emergency Department–Initiated Buprenorphine for Opioid Use Disorder JAMA Network This multicenter randomized study examined if 7-day extended-relea...
Lead: Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016–2023
18 Feb 2026
Contributed by Lukas
Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016–2023 Dr...
Lead: Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
10 Feb 2026
Contributed by Lukas
Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Canc...
Lead: Medication Availability for Alcohol Use Disorder in Substance Use Disorder Treatment Facilities
03 Feb 2026
Contributed by Lukas
Medication Availability for Alcohol Use Disorder in Substance Use Disorder Treatment Facilities JAMA Network Open This study examined the availability...
Lead: Public Views About Opioid Overdose and People With Opioid Use Disorder
27 Jan 2026
Contributed by Lukas
Public Views About Opioid Overdose and People With Opioid Use Disorder JAMA Network Open This study completed a national web-based survey of 1552 adul...
Lead: Did the illicit fentanyl trade experience a supply shock?
21 Jan 2026
Contributed by Lukas
Did the illicit fentanyl trade experience a supply shock? Science In the United States overdose deaths (ODDs) from synthetic opioids peaked in mid-20...
Lead: Barriers to Buprenorphine Initiation in Patients Using Fentanyl
13 Jan 2026
Contributed by Lukas
Barriers to Buprenorphine Initiation in Patients Using Fentanyl JAMA Network Open This is a survey study of 396 buprenorphine-prescribing clinicians i...
Lead: Productivity Losses From Substance Use Disorder in the U.S. in 2023
16 Dec 2025
Contributed by Lukas
Productivity Losses From Substance Use Disorder in the U.S. in 2023 American Journal of Preventive Medicine Information on morbidity-related productiv...
Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations
09 Dec 2025
Contributed by Lukas
Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations Substance Use and Addiction Journal This is a narrativ...
Lead: Very Low Nicotine Content Cigarettes for Smoking Cessation: Examining a Facilitated Extinction Approach and Dosing Schedule
02 Dec 2025
Contributed by Lukas
Very Low Nicotine Content Cigarettes for Smoking Cessation: Examining a Facilitated Extinction Approach and Dosing Schedule Drug and Alcohol Dependenc...
Lead: Fatal Opioid Overdoses by Historical and Contemporary Neighborhood-Level Structural Racism
25 Nov 2025
Contributed by Lukas
Fatal Opioid Overdoses by Historical and Contemporary Neighborhood-Level Structural Racism🔓 JAMA Health Forum This cross-sectional study of 796 ...
Lead: State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23
18 Nov 2025
Contributed by Lukas
State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23 Health Affairs While medications for...
Lead: Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine
11 Nov 2025
Contributed by Lukas
Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine JAMA Network This industry-sponsored, multicenter, open-label randomized clin...
Lead: States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24
04 Nov 2025
Contributed by Lukas
States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24 Health Affairs Multiple federal policy...
Lead: Ultra-processed food addiction in a nationally representative sample of older adults in the USA
28 Oct 2025
Contributed by Lukas
Ultra-processed food addiction in a nationally representative sample of older adults in the USA Addiction Using a cross-sectional online and telepho...
Lead: Alcohol Consumption Per Capita and Suicide: A Meta-Analysis
21 Oct 2025
Contributed by Lukas
Alcohol Consumption Per Capita and Suicide: A Meta-Analysis JAMA Network Open This meta-analysis that included 13 studies assessed if alcohol consum...
Lead: Measures of General Intelligence and Risk for Alcohol Use Disorder
14 Oct 2025
Contributed by Lukas
Measures of General Intelligence and Risk for Alcohol Use Disorder JAMA Psychiatry This male Swedish cohort study that included 573,855 participants a...
Lead: Medications for Opioid Use Disorder Playbook
11 Oct 2025
Contributed by Lukas
Medications for Opioid Use Disorder Playbook Agency for Healthcare Research and Quality (AHRQ) The AHRQ Integration Academy developed the Medication...
Lead: Cannabis Use During Pregnancy and Lactation
30 Sep 2025
Contributed by Lukas
Cannabis Use During Pregnancy and Lactation American College of Obstetricians & Gynecologists Cannabis is the most commonly used illicit drug unde...
Lead: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study
23 Sep 2025
Contributed by Lukas
Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study American Journal of Psychiatry This national retrospe...
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound
16 Sep 2025
Contributed by Lukas
Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compounds Science Advances Fentanyl and its analogs are a glo...
Lead: Evaluation of a Novel Patient-Centered Methadone Restart Protocol
09 Sep 2025
Contributed by Lukas
Evaluation of a Novel Patient-Centered Methadone Restart Protocol 🔓 JAMA Network Open Restarting methadone for patients who have had a gap in trea...
Lead: Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process
02 Sep 2025
Contributed by Lukas
Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process JAMA Network Open This survey study utilized a 3-rou...
Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting
26 Aug 2025
Contributed by Lukas
Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting JAMA Network Open Injectable-only buprenorphine protocols a...
Lead: Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression and/or PTSD
19 Aug 2025
Contributed by Lukas
Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression...
Lead: Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial
12 Aug 2025
Contributed by Lukas
Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial ...
Lead: Implementation Gaps in US Syringe Service Programs, 2022
05 Aug 2025
Contributed by Lukas
Implementation Gaps in US Syringe Service Programs, 2022 JAMA This study performed a cross-sectional analysis of the Syringe Services Programs in...
Lead: Co-involvement of stimulants with opioids in North America: A 'silent epidemic’
29 Jul 2025
Contributed by Lukas
Co-involvement of stimulants with opioids in North America: A 'silent epidemic’ Plos Mental Health The opioid epidemic unfolded in three distinct wa...
Lead: Did alcohol facilitate the evolution of complex societies?
22 Jul 2025
Contributed by Lukas
Did alcohol facilitate the evolution of complex societies? Humanities and Social Sciences Communications This study tested the “drunk” hypothesi...
Lead: Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients
15 Jul 2025
Contributed by Lukas
Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients JAMA Network Open This cohort study of 1,683 pati...
Lead: Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing
08 Jul 2025
Contributed by Lukas
Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing Journal of Gen...
Lead: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits
24 Jun 2025
Contributed by Lukas
Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits Journal of General Internal Medicine The A...
Lead: Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study
17 Jun 2025
Contributed by Lukas
Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study Drug and Alcohol Dependenc...
Lead: Bitter sensing protects Drosophila from developing experience-dependent cocaine consumption preference
10 Jun 2025
Contributed by Lukas
Bitter sensing protects Drosophila from developing experience-dependent cocaine consumption preference The Journal of Neuroscience Cocaine use disorde...
Lead: Memory function in patients with opioid dependence treated with buprenorphine and methadone in comparison with healthy persons
02 Jun 2025
Contributed by Lukas
Memory function in patients with opioid dependence treated with buprenorphine and methadone in comparison with healthy persons Scientific Reports Th...
Lead: Medicaid Unwinding and Changes in Buprenorphine Dispensing
28 May 2025
Contributed by Lukas
Medicaid Unwinding and Changes in Buprenorphine Dispensing JAMA Network Open Among Medicaid-insured adults with buprenorphine use, this cross-sectio...
Lead: Loneliness Among US Veterans With Problematic Substance Use: Results From the National Health and Resilience in Veterans Study
20 May 2025
Contributed by Lukas
Loneliness Among US Veterans With Problematic Substance Use: Results From the National Health and Resilience in Veterans Study Journal of Addiction Me...
Lead: The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption
13 May 2025
Contributed by Lukas
The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption New England Journal of Medicine In 2020, alcohol use was responsible f...
Lead: Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols
06 May 2025
Contributed by Lukas
Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols Substance Use and Addiction Journal Xylazine in the u...
Lead: Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial
29 Apr 2025
Contributed by Lukas
Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial Journal of the American Medical Association This 12-week randomized clini...
Lead: Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties
22 Apr 2025
Contributed by Lukas
Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian an...
Lead: Hospital Addiction Consultation Service and Opioid Use Disorder Treatment
15 Apr 2025
Contributed by Lukas
Hospital Addiction Consultation Service and Opioid Use Disorder Treatment JAMA Internal Medicine While medication for opioid use disorder (MOUD) is ef...
Lead: Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022
08 Apr 2025
Contributed by Lukas
Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022 Cancer Smoking prevalence peaked in the 50s and ...
Lead: Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years
01 Apr 2025
Contributed by Lukas
Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years JAMA Psychiatry This study examined the prevalence of presc...
Lead: Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans
25 Mar 2025
Contributed by Lukas
Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans JAMA Network Open This cross-sectional study exam...
Lead: Association Between Telehealth Initiation Of Stimulant Therapy And New Substance Use Disorder Diagnoses
18 Mar 2025
Contributed by Lukas
Association Between Telehealth Initiation Of Stimulant Therapy And New Substance Use Disorder Diagnoses Health Affairs During the COVID-19 pandemic, t...
Lead: The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021
11 Mar 2025
Contributed by Lukas
The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to...
Lead: Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness
04 Mar 2025
Contributed by Lukas
Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness Journal of the American Medical Association Utilizing a multistaged ...
Lead: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
25 Feb 2025
Contributed by Lukas
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder JAMA Psychiatry This randomized clinical trial explored if glucagon-like peptide ...
Lead: Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
19 Feb 2025
Contributed by Lukas
Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality JAMA Network Open This cohort study of 11.6 million people...
Lead: Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders
11 Feb 2025
Contributed by Lukas
Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders...
Lead: Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
04 Feb 2025
Contributed by Lukas
Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl JAMA Network Open The accumulation of fentanyl in fat is likely responsible ...
Lead: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
28 Jan 2025
Contributed by Lukas
Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning JAMA Psychiatry This longitudinal cohort study examined t...
Lead: Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice
21 Jan 2025
Contributed by Lukas
Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice American Journal of Psychiatry This narrative review discuss...
ASAM Weekly Special Episode: Dr. David Fiellin & Dr. Eric Strain sit down to discuss the concept of Treatment Refractory Addiction
14 Jan 2025
Contributed by Lukas
Host Dr. Nick Athanasiou is joined by Dr. David Fiellin and Dr. Eric Strain to discuss the concept of Treatment Refractory Addiction. Why does the f...
Lead: Review of Evidence on Alcohol and Health
14 Jan 2025
Contributed by Lukas
Review of Evidence on Alcohol and Health National Academies of Sciences, Engineering, and Medicine To inform the next edition of the Dietary Guideline...
Lead: The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
17 Dec 2024
Contributed by Lukas
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies Ps...
Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students
10 Dec 2024
Contributed by Lukas
Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students ...
Lead: Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine
04 Dec 2024
Contributed by Lukas
Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine Clinical Chemistry This study of xylazine pharmacokinetics used pla...
Lead: Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study
19 Nov 2024
Contributed by Lukas
Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study 🔓 Addiction Th...
Lead: Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity
05 Nov 2024
Contributed by Lukas
Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity 🔓 Alcohol Clinical and Experimental Rese...
Lead: Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
29 Oct 2024
Contributed by Lukas
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder JAMA Network This population-based retrospective cohort study assessed wh...
Lead: Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
22 Oct 2024
Contributed by Lukas
Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization 🔓 JAMA Network Open This cross-sectional study using health care...
Lead: Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review
15 Oct 2024
Contributed by Lukas
Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review The Lancet Regional Health Americas In the co...
Lead: Cannabis Policy Impacts Public Health and Health Equity
08 Oct 2024
Contributed by Lukas
Cannabis Policy Impacts Public Health and Health Equity National Academy of Sciences Engineering Medicine This report from the National Academies of S...
ASAM Weekly Special Episode: Dr. Shannon Miller talks PAM-7 and his path to addiction medicine [From the ASAM 55th Annual Conference]
30 Sep 2024
Contributed by Lukas
In this episode recorded live at ASAM's 55th Annual Conference in Fort Worth, TX, host Dr. Nick Athanasiou sat down with Dr. Shannon Miller to discuss...
Lead: Risk of Incident Psychosis and Mania With Prescription Amphetamines
24 Sep 2024
Contributed by Lukas
Risk of Incident Psychosis and Mania With Prescription Amphetamines The American Journal of Psychiatry This case-control study used electronic health ...
Lead: Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders
17 Sep 2024
Contributed by Lukas
Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders 🔓 JAMA Network Open This cross-sectional study of 9,43...
Lead: State-level racial and ethnic disparities in buprenorphine treatment duration in the United States
10 Sep 2024
Contributed by Lukas
State-level racial and ethnic disparities in buprenorphine treatment duration in the United States The American Journal on Addictions National trend...
Lead: Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial
04 Sep 2024
Contributed by Lukas
Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial 🔓 ...
Lead: The Lancet Psychiatry Commission on youth mental health
27 Aug 2024
Contributed by Lukas
The Lancet Psychiatry Commission on youth mental health🔓 The Lancet Psychiatry Mental ill health, which has been the leading health and social issu...
Lead: Alcohol Consumption Patterns and Mortality Among Older Adults With Health-Related or Socioeconomic Risk Factors
20 Aug 2024
Contributed by Lukas
Alcohol Consumption Patterns and Mortality Among Older Adults With Health-Related or Socioeconomic Risk Factors JAMA Network Open This British stu...
Lead: Physician Reluctance to Intervene in Addiction: A Systematic Review
13 Aug 2024
Contributed by Lukas
Physician Reluctance to Intervene in Addiction: A Systematic Review JAMA Network Open This systematic review of 283 articles explored the reasons phys...
ASAM Weekly Special Episode: Rapid Initiation of Injection Naltrexone for OUD | Dr. Matisyahu Shulman & Dr. Adam Bisaga
06 Aug 2024
Contributed by Lukas
Host Dr. Nick Athanasiou sat down with Drs. Matisyahu Shulman and Adam Bisaga to discuss the study they recently authored titled Rapid Initiation of I...
Lead: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders
06 Aug 2024
Contributed by Lukas
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders JAMA Psychiatry This is a survey study of 4,674 partic...
Lead: Psilocybin desynchronizes the human brain
30 Jul 2024
Contributed by Lukas
Psilocybin desynchronizes the human brain Nature To assess how human brain network changes relate to the subjective and lasting effects of psychedel...
Lead: Secondhand Nicotine Absorption From E-Cigarette Vapor vs Tobacco Smoke in Children
23 Jul 2024
Contributed by Lukas
Secondhand Nicotine Absorption From E-Cigarette Vapor vs Tobacco Smoke in Children JAMA Network Open This cross-sectional study of 1,777 US children...
Lead: Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study
16 Jul 2024
Contributed by Lukas
Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study 🔓 BMC Medicine This s...
Lead: Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial
09 Jul 2024
Contributed by Lukas
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial Nature Medicine The safety and t...
Lead: Global status report on alcohol and health and treatment of substance use disorders
02 Jul 2024
Contributed by Lukas
Global status report on alcohol and health and treatment of substance use disorders World Health Organization This report utilizes data from the WHO m...
Lead: Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths
25 Jun 2024
Contributed by Lukas
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths The New England Journal of Medicine HEALing (Helping to End Addiction Long...
Lead: Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl
18 Jun 2024
Contributed by Lukas
Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl Journal of Addiction Medicine The epidemic of fentanyl has led to increas...
Lead: Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
11 Jun 2024
Contributed by Lukas
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population Nature Communications In this retrospective...
Lead: Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco
04 Jun 2024
Contributed by Lukas
Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco Plos One This is a qualitative study describing the growing practic...
Lead: Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
28 May 2024
Contributed by Lukas
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder JAMA Network Standard initiation procedures (SP) for extended-release (XR)-naltrexone...
Lead: Burden of Mental Disorders and Suicide Attributable to Childhood Maltreatment
21 May 2024
Contributed by Lukas
Burden of Mental Disorders and Suicide Attributable to Childhood Maltreatment JAMA Psychiatry Studies have demonstrated that childhood maltreatment is...
Lead: Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States
14 May 2024
Contributed by Lukas
Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States International Jou...
Lead: Biomarkers of metal exposure in adolescent e-cigarette users
07 May 2024
Contributed by Lukas
Lead Story Biomarkers of metal exposure in adolescent e-cigarette users: correlations with vaping frequency and flavouring Tobacco Control Various m...
Lead: Association of regular opioid use with incident dementia and neuroimaging markers of brain health in chronic pain patients
30 Apr 2024
Contributed by Lukas
Association of regular opioid use with incident dementia and neuroimaging markers of brain health in chronic pain patients: analysis of UK Biobank The...
Lead: Preventing deaths after prison release
23 Apr 2024
Contributed by Lukas
Preventing deaths after prison release The Lancet Formerly incarcerated people have exceptionally poor health profiles and are at increased risk of pr...
Lead: Telling the story of the opioid crisis
16 Apr 2024
Contributed by Lukas
Lead Story: Telling the story of the opioid crisis: A narrative analysis of the TV series Dopesick PLOS One Dopesick (2021) is the first TV series...
Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration
09 Apr 2024
Contributed by Lukas
Lead Story: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration Drug and Alcohol Dependence The...
Lead: Epigenome-wide association study on methamphetamine dependence
02 Apr 2024
Contributed by Lukas
Lead Story: Epigenome-wide association study on methamphetamine dependence Addiction Biology The authors of this study postulate that some of the biol...
Lead: Disposable E-Cigarette Use and Subsequent Use Patterns in Adolescents and Young Adults
26 Mar 2024
Contributed by Lukas
Disposable E-Cigarette Use and Subsequent Use Patterns in Adolescents and Young Adults Pediatrics Utilizing sequential surveys in adolescents and yo...
Lead: Adolescent Δ8-THC and Marijuana Use in the US
19 Mar 2024
Contributed by Lukas
Lead Story: Adolescent Δ8-THC and Marijuana Use in the US 🔓 JAMA D8-THC is synthesized from legal hemp plants (with low D9-THC) and has intoxic...
Lead: Association of Cannabis Use With Cardiovascular Outcomes Among US Adults
12 Mar 2024
Contributed by Lukas
Lead Story: Association of Cannabis Use With Cardiovascular Outcomes Among US Adults Journal of the American Heart Association Cannabis use has incr...
Lead: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine
05 Mar 2024
Contributed by Lukas
Lead Story: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine Journal of Addiction Medicine To identify whether buprenorphine ...